| Authors: |
Srinivasan S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington., Richardson BA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Department of Biostatistics.; Department of Global Health., Wallis JM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington., Fiedler TL; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington., Strenk SM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington., Hoffman NG; Department of Laboratory Medicine, University of Washington, Seattle, Washington., Proll S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington., Chirenje ZM; Clinical Trial Research Center, University of Zimbabwe, Harare., Livant EW; Magee-Womens Research Institute, Pittsburgh, Pennsylvania., Fredricks DN; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Department of Medicine, University of Washington, Seattle., Hillier SL; Magee-Womens Research Institute, Pittsburgh, Pennsylvania.; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pennsylvania., Marrazzo JM; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland. |
